Published in Emerg Infect Dis on September 01, 2005
The burden of human African trypanosomiasis. PLoS Negl Trop Dis (2008) 2.53
Conflict and emerging infectious diseases. Emerg Infect Dis (2007) 1.36
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg Infect Dis (2008) 1.33
Human African trypanosomiasis in areas without surveillance. Emerg Infect Dis (2010) 1.30
Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis (2007) 1.04
Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis (2011) 1.04
Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo. PLoS Negl Trop Dis (2012) 0.99
Screening of Trypanosoma brucei gambiense in domestic livestock and tsetse flies from an insular endemic focus (Luba, Equatorial Guinea). PLoS Negl Trop Dis (2010) 0.97
Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis. Emerg Infect Dis (2007) 0.93
Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan. Parasit Vectors (2012) 0.92
Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency? PLoS Negl Trop Dis (2012) 0.91
A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness"). PLoS Negl Trop Dis (2015) 0.90
Cryptic diversity within the major trypanosomiasis vector Glossina fuscipes revealed by molecular markers. PLoS Negl Trop Dis (2011) 0.87
Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis. Am J Trop Med Hyg (2010) 0.87
Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk. Int J Health Geogr (2015) 0.80
Trypanosoma brucei gambiense adaptation to different mammalian sera is associated with VSG expression site plasticity. PLoS One (2013) 0.78
Tsetse Flies (Glossina) as Vectors of Human African Trypanosomiasis: A Review. Biomed Res Int (2016) 0.76
The epidemiology of trypanosomiasis in Rumphi district, Malawi: a ten year retrospective study. Malawi Med J (2009) 0.75
A systematic review and meta-analysis of trypanosome prevalence in tsetse flies. BMC Vet Res (2017) 0.75
Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo. PLoS One (2017) 0.75
Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet (2002) 11.72
A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis. Ann Soc Belg Med Trop (1978) 4.10
Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1998) 3.93
Resurgence of sleeping sickness in Tambura County, Sudan. Am J Trop Med Hyg (1999) 2.24
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health (2004) 1.89
In the heart of darkness: sleeping sickness in Zaire. Lancet (1996) 1.88
Re-emergence of epidemic sleeping sickness in southern Sudan. Trop Med Int Health (2001) 1.50
Sleeping sickness resurgence in the DRC: the past decade. Trop Med Int Health (2001) 1.48
[Control of human African trypanosomiasis in Luba in equatorial Guinea:evaluation of three methods]. Bull World Health Organ (1991) 1.15
[Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991)]. Bull Soc Pathol Exot (1995) 1.14
[Sleeping sickness in the region of the town of Kinshasa: a retrospective analysis during the surveillance period 1996-2000]. Trop Med Int Health (2003) 1.07
[Control of Trypanosoma gambiense trypanosomiasis. Evaluation of a strategy based on the treatment of serologically suspected cases with a single dose of diminazene]. Ann Soc Belg Med Trop (1994) 0.88
Key indicators for the monitoring and evaluation of control programmes of human African trypanosomiasis due to Trypanosoma brucei gambiense. Trop Med Int Health (1998) 0.85
[Trypanosomiasis caused by T. b. gambiense: methods of control]. Bull Soc Pathol Exot Filiales (1988) 0.85
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med (2008) 6.70
The future of Chagas disease control. Trends Parasitol (2006) 4.65
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis (2013) 4.03
Treatment of human African trypanosomiasis--present situation and needs for research and development. Lancet Infect Dis (2002) 3.73
Equity in financing and use of health care in Ghana, South Africa, and Tanzania: implications for paths to universal coverage. Lancet (2012) 3.42
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health (2008) 3.01
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis (2009) 2.56
Beyond fragmentation and towards universal coverage: insights from Ghana, South Africa and the United Republic of Tanzania. Bull World Health Organ (2008) 2.54
Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis (2010) 2.50
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health (2008) 2.28
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis (2008) 2.24
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis (2003) 2.11
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis (2012) 2.00
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health (2004) 1.89
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health (2004) 1.89
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis (2008) 1.73
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis (2011) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Human trypanosomiasis caused by Trypanosoma evansi in India: the first case report. Am J Trop Med Hyg (2005) 1.62
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
Present situation of vector-control management in Bangladesh: a wake up call. Health Policy (2008) 1.54
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis (2010) 1.53
Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health (2008) 1.51
Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol (2008) 1.50
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis (2010) 1.48
Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis (2009) 1.43
Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health (2006) 1.43
Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis (2010) 1.42
Challenges in HIV and visceral Leishmania co-infection: future research directions. Trop Med Int Health (2010) 1.41
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect (2007) 1.40
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr (2009) 1.40
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health (2010) 1.36
The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion (2005) 1.35
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis (2010) 1.35
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health (2006) 1.35
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg Infect Dis (2008) 1.33
The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health (2010) 1.30
Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg (2010) 1.30
Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis (2010) 1.29
Interactions between Global Health Initiatives and country health systems: the case of a neglected tropical diseases control program in Mali. PLoS Negl Trop Dis (2010) 1.26
Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med Hyg (2009) 1.22
Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health (2008) 1.21
Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study. BMC Public Health (2008) 1.20
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol (2012) 1.20
Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol (2010) 1.16
Latent infection with Leishmania donovani in highly endemic villages in Bihar, India. PLoS Negl Trop Dis (2013) 1.16
Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health (2011) 1.16
PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop Med Int Health (2009) 1.16
Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia. Trans R Soc Trop Med Hyg (2008) 1.14
Phlebotomus argentipes seasonal patterns in India and Nepal. J Med Entomol (2010) 1.14
Who pays and who benefits from health care? An assessment of equity in health care financing and benefit distribution in Tanzania. Health Policy Plan (2012) 1.14
Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review. PLoS Negl Trop Dis (2012) 1.13
Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis (2007) 1.13
Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl Trop Dis (2011) 1.11
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
Bayesian latent class models with conditionally dependent diagnostic tests: a case study. Stat Med (2008) 1.10
Do patents prevent access to drugs for HIV in developing countries? JAMA (2002) 1.09
Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis (2011) 1.08
Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis (2014) 1.07
Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. Indian J Med Res (2012) 1.07
Primary health care vs. emergency medical assistance: a conceptual framework. Health Policy Plan (2002) 1.06
Financing vaccinations - the South African experience. Vaccine (2012) 1.06
Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. PLoS One (2011) 1.06
Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health (2006) 1.04
Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis (2007) 1.04
Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo. Trop Med Int Health (2009) 1.04
[The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense]. Trop Med Int Health (2005) 1.03
Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg (2011) 1.03
Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital. Pediatr Infect Dis J (2010) 1.02
Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health (2006) 1.02
Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA. Trop Med Int Health (2010) 1.02
Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine (2006) 1.02
Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential. Trop Med Int Health (2007) 1.02
Atypical human infections by animal trypanosomes. PLoS Negl Trop Dis (2013) 1.01
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis (2011) 1.01
Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg (2007) 1.01
Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland. J Clin Microbiol (2010) 1.01